A federal judge temporarily halted significant funding cuts to the National Institutes of Health (NIH) proposed by the Trump administration, aiming to limit indirect expenses for medical research. These cuts would jeopardize research in crucial areas including Alzheimer’s, cancer, and heart disease, ultimately harming patient care and job security in healthcare. A coalition of 22 states and various research organizations successfully challenged the policy in court, emphasizing that the indirect costs are essential for research operations. Judge Angel Kelley issued a preliminary injunction, maintaining funding levels while the legal proceedings continue.
The Trump administration's new policy sought to cap indirect costs at 15%, drastically underfunding medical research and risking patient care and job security.
Federal lawsuits argued that this funding cut would lead to "irreparable harm," particularly impacting the vitality of research in vital medical fields.
Judge Angel Kelley issued a preliminary injunction against the funding cuts, emphasizing the importance of protecting biomedical research funding as lawsuits proceed.
The NIH allocated approximately $35 billion last year, which is vital for both direct and indirect expenses essential to medical research and healthcare innovation.
Collection
[
|
...
]